실적분석 2026년 8월 12일

Octave Intelligence ($OCTV) Q2 2026 Earnings Analysis — Adjusted EPS Beat and Fresh Guidance Tempered by Growth-Slowdown Concerns

Earnings Scorecard

Revenue: $398 million (-4% year-over-year; estimate $397 million) ✅ Beat

EPS: Adjusted $0.36 (estimate $0.32) ✅ Beat

Guidance: Newly issued — Q3 2026 revenue of $400–$410 million; full-year revenue of $1.635–$1.665 billion

Stock Reaction: After-hours -14.10% ($16.94) — as of 08-12, 20:51 Korea time

The Positives

Adjusted earnings beat: Adjusted EPS of $0.36 came in above the $0.32 estimate

Recurring revenue growth: Recurring revenue of $283 million (+6%); annualized recurring revenue of $1.143 billion (+7%)

Cash generation: Operating cash flow of $125 million; free cash flow of $93 million

Since spinning off from Hexagon, the company has shifted toward a subscription-and-maintenance-centric model, lifting recurring revenue and annualized recurring revenue to core metrics. SAS (software-as-a-service) revenue growth of 21% and solid cash flow underpinned that transition.

The Negatives

Total revenue contraction: Total revenue of $398 million declined 4% year-over-year (organic constant currency -1%)

Large non-cash impairment: Combined goodwill and trademark impairment of $2.135 billion drove a GAAP net loss of $1.971 billion

Soft full-year growth outlook: 2026 total revenue organic constant-currency growth guidance of 0–2%

Softness in non-recurring revenue, including license and services, weighed on total revenue, and the fact that market capitalization dipped below book value triggered the impairment review — adding a psychological burden. Management noted that there is no cash impact and that it does not reflect a change in outlook, but the large GAAP loss itself is a daunting figure for novice investors.

What Management Said

CEO Mattias Stenberg emphasized momentum as an independent company and the growth of SAS, explaining that during the business-model transition, recurring revenue and annualized recurring revenue are better performance metrics than total revenue. He also reiterated confidence in the medium-term financial-target trajectory shared at the March investor day.

Market Reaction and Key Points Ahead

Adjusted results topped estimates, but the combination of negative total-revenue growth, the muted full-year revenue-growth outlook (0–2%), and the impairment triggered by market cap falling below book value appears to have cooled conviction in the growth story quickly.

In Q3, watch whether total revenue recovers into the guided range of $400–$410 million and whether recurring-revenue growth holds up.

Track whether annualized recurring revenue stays on track for the year-end target of $1.185–$1.205 billion and whether license weakness extends further.

It will be important to check whether post-impairment adjusted operating margin (full-year target: 30%) and free-cash-flow margin (full-year target: 20%) are consistent with guidance.